Target intelligence / Profile preview

AMP-activated protein kinase – Forkhead box protein O3A pathway (AMPK–FOXO3A pathway)

Target
AMPK–FOXO3A pathway
Molecular classification
Signaling Pathway
01

Overview

The phrase 'AMP-activated protein kinase/Forkhead box protein O3A pathway' refers to a functional signaling interaction between two distinct proteins: AMP-activated protein kinase (AMPK) and Forkhead box protein O3A (FOXO3A). It is not a single molecular target or receptor. AMPK is a cellular energy sensor and kinase, while FOXO3A is a transcription factor. Their functional relationship, the AMPK–FOXO3A pathway, defines how AMPK phosphorylates and activates FOXO3A in response to metabolic and oxidative stress, coordinating cellular responses such as gene activation for stress response, DNA repair, and antioxidant systems. As such, therapeutic approaches typically target the individual components (AMPK or indirectly FOXO3A) rather than the 'pathway' as a singular, discrete entity.

02

Mechanism of action

This 'pathway' describes the functional interaction where AMP-activated protein kinase (AMPK) phosphorylates and activates Forkhead box protein O3A (FOXO3A) in response to metabolic stress. Drugs modulate the activity of the individual components of this pathway (AMPK or FOXO3A), thereby influencing the overall pathway's signaling.

03

Biological functions

Coordination of cellular response to metabolic stressCoordination of cellular response to oxidative stressActivation of stress response genesRegulation of DNA repairRegulation of antioxidant systems
04

Disease associations

Cell survivalApoptosisCancerMetabolic diseaseNeurodegenerative disease
05

Safety considerations

Risk for hypoglycemia (associated with AMPK activators)Cardiac side effects (bradycardia, associated with AMPK activators)Gastrointestinal intolerance (especially at high drug dosages, associated with AMPK activators)Potential for inducing apoptosis in non-target tissues (associated with FOXO3A activation)
06

Interacting drugs

Metformin

4 more in the full profile.

07

Biomarkers

Phosphorylation status of AMPKα (Thr172)Nuclear localization of FOXO3AFOXO3A phosphorylation status

Beyond the preview

Go deeper on AMP-activated protein kinase – Forkhead box protein O3A pathway (AMPK–FOXO3A pathway).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AMP-activated protein kinase – Forkhead box protein O3A pathway (AMPK–FOXO3A pathway).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call